Answer
Aranesp (darbepoetin alfa) is indicated to treat symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Sources for this answer
- Aranesp solution for injection in pre-filled syringe / Aranesp solution for injection in pre-filled syringe with needle guardAmgen Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked